Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan

被引:17
|
作者
Ali, Monadil H. [1 ,2 ]
Alrasheedy, Alian A. [3 ]
Hassali, Mohamed Azmi [1 ]
Kibuule, Dan [4 ]
Godman, Brian [1 ,5 ,6 ,7 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Minden 11800, Malaysia
[2] Northern Border Univ, Coll Pharm, Dept Clin Pharm, Rafha 91911, Saudi Arabia
[3] Qassim Univ, Unaizah Coll Pharm, Qasim 51911, Saudi Arabia
[4] Univ Namibia, Fac Hlth Sci, Sch Pharm, 340 Mandume Ndemufayo Ave Pioneers Pk, Windhoek 13301, Namibia
[5] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, SE-14186 Stockholm, Sweden
[6] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland
[7] Sefako Makgatho Hlth Sci Univ, Sch Pharm, ZA-0204 Pretoria, South Africa
来源
ANTIBIOTICS-BASEL | 2019年 / 8卷 / 03期
关键词
MDR-TB; Predictors; Sudan; Tuberculosis; RISK-FACTORS; DRUG-RESISTANCE; PATTERN; STATE;
D O I
10.3390/antibiotics8030090
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Multidrug-resistant tuberculosis (MDR-TB) is a global public health threat and burden on the health system. This is especially the case in high tuberculosis (TB) prevalence countries, such as Sudan. Consequently, this study aimed to ascertain the predictors of MDR-TB in Sudan to provide future guidance. An unmatched case-control study to assess the predictors of MDR-TB infections among the Sudanese population was conducted from August 2017 to January 2018 at Abu-Anga referral hospital. Patients' data was gathered from patients' cards and via interviews. A structured pre-validated questionnaire was used to gather pertinent information, which included sociodemographic characteristics and other relevant clinical data. Univariate and multivariate logistic regression analysis was employed to determine the predictors of MDR-TB infection. 76 of the 183 patients interviewed (41.5%) had MDR-TB cases. The independent predictors for MDR-TB were living in rural areas [adjusted odds ratio (aOR) = 3.1 (95% confidence interval (CI): 1.2-8.2)], treatment failure [aOR = 56.9 (10.2-319.2)], and smoking [(aOR = 4 (1.2-13.2)], whereas other sociodemographic factors did not predict MDR-TB. In conclusion, the study showed that a history of smoking, living in rural areas, and a previous treatment failure were the predictors of MDR-TB in Sudan. The latter factors are most likely due to issues that are related to access and adherence to treatment and lifestyle. The existence of any of these factors among newly diagnosed TB patients should alert clinicians for the screening of MDR-TB. The implementation of directly observed treatment (DOT) and health education are crucial in stopping the spread of MDR-TB in Sudan.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: A systematic review and meta-analysis of the prevalence, determinants and treatment outcome
    Girum T.
    Muktar E.
    Lentiro K.
    Wondiye H.
    Shewangizaw M.
    Tropical Diseases, Travel Medicine and Vaccines, 4 (1)
  • [32] Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India
    Prakash, Ravi
    Kumar, Dilip
    Gupta, Vinod K.
    Jain, Sanjay
    Chauhan, Devendra S.
    Tiwari, Pramod K.
    Katoch, Vishwa M.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2016, 9 (03) : 289 - 297
  • [33] Role Of Nutrition Status In Multidrug Resistant Tuberculosis (mdr-Tb) Conversion
    Librianty, N.
    Soepandi, P.
    Handayani, D.
    Fuady, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] Factors associated with multidrug-resistant tuberculosis (MDR-TB) in Bhutan: A nationwide case-control study
    Tenzin, Chador
    Chansatitporn, Natkamol
    Dendup, Tashi
    Dorji, Tandin
    Lhazeen, Karma
    Tshering, Dorji
    Pelzang, Thinley
    PLOS ONE, 2020, 15 (07):
  • [35] Epidemiology and spatial distribution of cases of multidrug-resistant tuberculosis (mdr-tb) in Brazil, 2008-2012
    de Almeida, Manoel Guedes
    Marques Barbosa, Debora Regina
    da Silva Almeida, Dhony Ferraz
    REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO, 2013, 3 (04): : 117 - 122
  • [36] Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products
    Nora de Souza, Marcus Vinicius
    FITOTERAPIA, 2009, 80 (08) : 453 - 460
  • [37] Increase in Multidrug-resistant Tuberculosis (MDR-TB) in Alberta Among Foreign-born Persons: Implications for Tuberculosis Management
    Long, Richard
    Langlois-Klassen, Deanne
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2013, 104 (01): : E22 - E27
  • [38] Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia
    Biresaw Demile
    Amare Zenebu
    Haile Shewaye
    Siqing Xia
    Awoke Guadie
    BMC Infectious Diseases, 18
  • [39] Identification of Serum Cytokine Biomarkers Associated with Multidrug Resistant Tuberculosis (MDR-TB)
    Mensah, Gloria Ivy
    Boakye, Alahaman Nana
    Basingnaa, Anthony
    Owusu, Enid
    Antwi-Baffour, Samuel
    Ofori, Michael Fokuo
    Addo, Kennedy Kwasi
    Jackson-Sillah, Dolly
    Adekambi, Toidi
    IMMUNO, 2021, 1 (04): : 400 - 409
  • [40] Management of multidrug resistant tuberculosis (MDR-TB) - Monitoring is the key to successful outcome
    Akshata, J. S.
    Chakrabarthy, Anushree
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2016, 65 (02): : 447 - 450